General Outcome Measurements: GAD-2

Anxiety symptoms can influence sleep, recovery, pain, training consistency, work capacity, concentration, confidence, motivation and daily participation.

The GAD-2 was derived from the first two items of the GAD-7. It asks about two core anxiety symptoms: feeling nervous, anxious or on edge, and being unable to stop or control worrying.

Because it only has two items, the GAD-2 is often used as a quick first-step screening tool. A positive screen should usually lead to further assessment, such as completing the full GAD-7, clinical discussion or referral where appropriate.

The GAD-2 should be used within professional scope. Elevated scores should be handled sensitively and should not be treated as a diagnosis.

Quick Summary

• Outcome measure: Generalised Anxiety Disorder 2-item scale
• Abbreviation: GAD-2
• Category: Anxiety symptom screening questionnaire
• Type: Self-report screening measure
• Number of items: 2
• Recall period: Previous two weeks
• Score range: 0–6
• Higher score means: Greater anxiety symptom frequency
• Common cut-off: 3 or more out of 6
• Best used for: Brief anxiety symptom screening
• Key limitation: GAD-2 is not a diagnostic tool

What Is the GAD-2?

The GAD-2 is a two-item screening questionnaire.

It asks how often, over the past two weeks, the person has been bothered by:

• feeling nervous, anxious or on edge
• not being able to stop or control worrying

Each item is scored from 0 to 3.

The total score ranges from 0 to 6.

A higher score indicates more frequent anxiety symptoms.

Why It Is Used

The GAD-2 is used because it provides a very quick way to screen for anxiety symptoms.

A client may report:

• nervousness
• worry
• difficulty relaxing
• sleep disruption
• reduced concentration
• reduced confidence
• activity avoidance
• increased tension
• lower training consistency
• difficulty managing life load

The GAD-2 may help professionals:

• establish a quick baseline
• identify whether further screening may be useful
• support sensitive wellbeing conversations
• monitor anxiety symptom change over time
• decide whether the full GAD-7 may be appropriate
• support referral-aware practice
• consider how anxiety symptoms may interact with pain, sleep, recovery and participation

The score should be interpreted alongside client discussion, risk context, goals, sleep, workload, pain, function, support systems and professional judgement.

What It Measures

The GAD-2 measures the frequency of two anxiety symptoms over the previous two weeks.

It may provide insight into:

• nervousness
• anxiety
• feeling on edge
• uncontrollable worry
• possible need for further assessment
• anxiety symptom change over time

It does not directly measure:

• diagnosis
• full anxiety disorder criteria
• panic symptoms
• trauma symptoms
• obsessive-compulsive symptoms
• depression
• suicide risk
• cause of symptoms
• work readiness
• sport readiness
• treatment need

Who It Is Useful For

The GAD-2 may be useful for:

• wellbeing professionals
• allied health support teams
• rehabilitation practitioners working within scope
• exercise professionals using referral-aware screening
• movement assessment professionals
• workplace wellbeing teams
• students learning outcome measures
• professionals monitoring distress alongside physical symptoms

It may be relevant for clients with:

• persistent pain
• sleep disruption
• high stress
• anxiety symptoms
• reduced confidence
• reduced recovery
• fear of movement or reinjury
• return-to-training concerns
• high life load
• reduced participation linked with worry or nervousness

When to Use This Outcome Measure

Use the GAD-2 when you want a quick screen for anxiety symptoms over the past two weeks.

It may be useful at:

• baseline wellbeing screening
• initial assessment
• progress review
• persistent pain assessment
• reassessment
• return-to-training monitoring
• workplace wellbeing review
• referral-support discussion

The GAD-2 is especially useful when time is limited and a very brief screen is needed.

When Not to Use or When to Be Cautious

Use caution when:

• the client is in crisis
• suicide or self-harm concerns are present
• distress is severe or rapidly worsening
• the professional is not trained to respond appropriately
• the score is being used as a diagnosis
• the result is interpreted without discussion
• language, literacy or cultural context affects responses
• the client is younger than the intended population for the version used

The GAD-2 should not be used to:

• diagnose generalised anxiety disorder
• diagnose any anxiety disorder
• assess suicide risk on its own
• replace mental health assessment
• replace medical assessment
• determine treatment need on its own
• clear someone for sport or work
• replace professional judgement

If a client reports risk of harm, severe distress or safety concerns, follow the relevant referral, escalation or emergency process.

Equipment or Resources Required

You need:

• GAD-2 questionnaire
• scoring instructions
• baseline and retest dates
• appropriate privacy and consent context
• referral or escalation pathway if elevated scores or safety concerns occur

Optional related information may include:

• GAD-7 if further anxiety screening is needed
• PHQ-2 or PHQ-9 where mood screening is appropriate
• sleep notes
• pain ratings
• fatigue ratings
• workload notes
• recovery notes
• training exposure
• relevant referral notes

Administration Protocol / Practice

Setup

Explain the purpose of the questionnaire before the client completes it.

Example wording:

“This short questionnaire asks about two common anxiety symptoms over the past two weeks. It does not diagnose an anxiety disorder, but it can help us decide whether further screening, support or referral may be useful.”

Format

The GAD-2 can be completed:

• on paper
• digitally
• independently
• verbally if assistance is required
• before a session
• during reassessment
• as part of wellbeing or progress monitoring

Client Instructions

Ask the client to:

• answer based on the past two weeks
• choose how often each problem has bothered them
• answer both items where possible
• avoid overthinking each item
• ask for clarification if they do not understand an item
• complete the same version at retest

Scoring Process

Each item is scored:

• 0 = Not at all
• 1 = Several days
• 2 = More than half the days
• 3 = Nearly every day

Add both items together.

Total score range:

• 0–6

Higher scores indicate greater anxiety symptom frequency.

A score of 3 or more is commonly used as a positive screening result.

Retesting Considerations

Retest at meaningful time points, such as:

• baseline
• progress review
• after a support period
• after major workload or training change
• after a symptom flare-up
• follow-up monitoring

For consistency, record the same version, date, context over the past two weeks, sleep, workload, major life stressors and whether support or referral has changed.

Safety Notes

The GAD-2 does not assess suicide risk directly.

If a client reports severe distress, risk of harm, crisis or safety concerns, do not rely on the GAD-2 alone. Follow appropriate referral, escalation or emergency procedures.

Scoring and Interpretation

The GAD-2 total score ranges from 0 to 6.

Higher scores indicate more frequent anxiety symptoms over the previous two weeks.

Common interpretation:

• 0–2: lower likelihood of clinically significant anxiety symptoms
• 3–6: positive screen; further assessment may be warranted

A positive screen should usually lead to further assessment rather than a diagnostic label.

What a High Score May Suggest

A higher GAD-2 score may suggest:

• more frequent anxiety symptoms
• more frequent worry
• feeling nervous, anxious or on edge
• possible need for further screening
• value in completing the full GAD-7
• possible referral or support discussion where appropriate

A high score does not diagnose anxiety.

What a Low Score May Suggest

A lower score may suggest fewer anxiety symptoms during the past two weeks.

A low score does not rule out anxiety concerns, especially if symptoms fluctuate, the client under-reports, or anxiety appears in situations not captured by the two items.

What the Score Does Not Prove

A GAD-2 score does not prove:

• diagnosis
• cause of anxiety symptoms
• risk level
• suicide risk status
• treatment need
• work readiness
• sport readiness
• whether one intervention caused the change

How to Explain the Result Safely

Example wording:

“Your GAD-2 score gives us a quick snapshot of anxiety symptoms over the past two weeks. It does not diagnose a condition, but it can help us decide whether further screening, support or referral may be useful.”

What the Score May Mean in Different Client Populations

General Fitness Clients

For general fitness clients, GAD-2 scores may help show whether worry or nervousness may be affecting motivation, sleep, exercise consistency or recovery.

Sport and Performance Clients

For athletes, elevated scores may reflect competition pressure, injury concerns, performance anxiety, training stress, life load or broader mental health symptoms.

The score should not be used to determine sport readiness on its own.

Older Adults

For older adults, interpretation should consider general health, medication context, social support, sleep, pain, cognitive factors and life changes.

Youth Clients

For youth clients, use age-appropriate screening processes and consider parent/guardian support, school context and referral pathways.

Clients With Persistent Pain

For persistent pain clients, the GAD-2 may help monitor anxiety symptoms that interact with pain, sleep, fatigue, movement confidence and participation.

Workplace or Occupational Populations

For workplace populations, scores should be interpreted with consideration of workload, role demands, psychological safety, support and occupational health processes.

Meaningful Change, MCID, MDC and Responsiveness

The GAD-2 is primarily a brief screening measure rather than a detailed progress outcome measure.

High-quality, universally applicable MCID or MDC values for every GAD-2 population are limited.

Change should be interpreted with:

• baseline comparison
• repeated measurement
• discussion with the client
• sleep and workload context
• support or referral changes
• pain and function changes
• client goals
• professional judgement

Because the GAD-2 has only two items, small score changes should be interpreted cautiously. When more detailed monitoring is needed, the full GAD-7 may be more useful.

Normative Data, Reference Values or Comparative Data

The GAD-2 is generally interpreted using its score range and screening cut-off rather than broad normative values.

A score of 3 or more is commonly used as a positive screen.

However, performance may vary by:

• population
• age
• language
• culture
• health context
• pain status
• pregnancy or postpartum context
• work or study load
• assessment setting

Practical comparison guidance:

• compare the client with their own baseline
• interpret the score with current context
• use the cut-off as screening only
• consider the full GAD-7 if further detail is needed
• avoid treating a positive screen as a diagnosis
• ensure referral pathways are available when needed

Reliability and Validity

The GAD-2 has been widely studied as an ultra-brief anxiety screening measure.

It is derived from the first two items of the GAD-7 and has shown useful screening performance for generalised anxiety disorder and other anxiety disorders in primary care and other settings.

A commonly cited cut-off of 3 has been reported to provide a useful balance between sensitivity and specificity for identifying possible generalised anxiety disorder.

More recent systematic review evidence continues to support the GAD-2 and GAD-7 as commonly used anxiety screening measures, while also emphasising that screening tools do not replace diagnostic assessment.

Reliability and validity are strongest when:

• the correct version is used
• both items are completed
• the client understands the timeframe
• the score is interpreted as screening
• elevated scores are followed by appropriate assessment or referral
• results are interpreted within context

Interpret cautiously when:

• the client is in crisis
• language or culture affects responses
• symptoms are complex or severe
• the score is used without discussion
• the result is used as a diagnosis
• safety concerns are present

Common Errors and Limitations

Common errors include:

• treating GAD-2 as a diagnosis
• using it without a referral pathway
• ignoring severe distress or safety concerns
• assuming a low score rules out anxiety
• interpreting the score without discussion
• using it to clear someone for sport or work
• failing to follow up a positive screen
• using it outside professional scope

Limitations include:

• only two items
• self-report can be influenced by willingness to disclose
• it captures the past two weeks only
• it does not assess suicide risk directly
• it does not assess all anxiety disorders in detail
• it does not assess depression, trauma or other concerns
• cut-off performance varies by population
• it should not replace mental health assessment where needed

Practical Applications

The GAD-2 may help professionals:

• quickly screen anxiety symptoms
• document baseline worry and nervousness
• decide whether the full GAD-7 may be useful
• support referral-aware conversations
• monitor broad change over time
• understand how anxiety symptoms may interact with pain, sleep and training
• improve whole-person assessment reasoning

For persistent pain and rehabilitation contexts, the GAD-2 can help identify whether anxiety symptoms may be interacting with pain, activity tolerance or participation.

For sport and workplace contexts, it can support screening and monitoring, but results should be handled confidentially and within appropriate professional boundaries.

FAQs

What does the GAD-2 measure?

The GAD-2 measures two anxiety symptoms over the past two weeks: feeling nervous, anxious or on edge, and not being able to stop or control worrying.

How many items are in the GAD-2?

The GAD-2 has 2 items.

How is the GAD-2 scored?

Each item is scored from 0 to 3. The total score ranges from 0 to 6.

What is the GAD-2 cut-off?

A score of 3 or more is commonly used as a positive screening result.

Does the GAD-2 diagnose anxiety?

No. The GAD-2 is a screening tool and does not diagnose anxiety disorders on its own.

What should happen after a positive screen?

A positive screen may support further assessment, such as completing the GAD-7, discussing symptoms further or considering referral where appropriate.

Does the GAD-2 assess suicide risk?

No. The GAD-2 does not directly assess suicide risk. Safety concerns require appropriate assessment and escalation.

Is the GAD-2 useful for progress tracking?

It can be used for broad monitoring, but the full GAD-7 may be more useful when detailed anxiety symptom tracking is needed.

Key Takeaways

• GAD-2 is a 2-item anxiety symptom screening questionnaire.
• It asks about symptoms over the past two weeks.
• Scores range from 0 to 6.
• A score of 3 or more is commonly used as a positive screen.
• GAD-2 does not diagnose anxiety disorders.
• It does not assess suicide risk directly.
• Elevated scores should be handled sensitively and within professional scope.
• Interpretation is strongest when combined with discussion, context, support pathways and professional judgement.

References

Kroenke, K., Spitzer, R. L., Williams, J. B. W., Monahan, P. O., & Löwe, B. (2007). Anxiety disorders in primary care: Prevalence, impairment, comorbidity, and detection. Annals of Internal Medicine, 146(5), 317–325. https://doi.org/10.7326/0003-4819-146-5-200703060-00004

National Collaborating Centre for Mental Health. (2011). Common mental health disorders: Identification and pathways to care. National Institute for Health and Care Excellence. Appendix 13: Generalized Anxiety Disorder Scale (2 items) Questionnaire. https://www.ncbi.nlm.nih.gov/books/NBK92248/

Plummer, F., Manea, L., Trepel, D., & McMillan, D. (2016). Screening for anxiety disorders with the GAD-7 and GAD-2: A systematic review and diagnostic meta-analysis. General Hospital Psychiatry, 39, 24–31. https://doi.org/10.1016/j.genhosppsych.2015.11.005

Sapra, A., Bhandari, P., Sharma, S., Chanpura, T., & Lopp, L. (2020). Using Generalized Anxiety Disorder-2 (GAD-2) and GAD-7 in a primary care setting. Cureus, 12(5), e8224. https://doi.org/10.7759/cureus.8224